Description
M1 A2 (58-66) is an epitope of influenza matrix protein M1 that is recognizable by CD8+ T cells; this epitope could be used in the design of influenza vaccines.
| Product Unit Size | Cost | Quantity | Stock |
|---|
M1 A2 (58-66) is an epitope of influenza matrix protein M1 that is recognizable by CD8+ T cells; this epitope could be used in the design of influenza vaccines.
| Cas No. | 141368-69-6 |
|---|---|
| Purity | ≥95% |
| Formula | C49H75N9O11 |
| Formula Wt. | 966.2 |
| IUPAC Name | Glycyl-L-isoleucyl-L-leucylglycyl-L-phenylalanyl-L-valyl-L-phenylalanyl-L-threonyl-L-leucine |
| Synonym | CEF1, Influenza Matrix Protein M1 (58 - 66), |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zhou V, Yassai MB, Regunathan J, et al. The functional CD8 T cell memory recall repertoire responding to the influenza A M1(58-66) epitope is polyclonal and shows a complex clonotype distribution. Hum Immunol. 2013 Jul;74(7):809-17. PMID: 23295548.
Petrova GV, Naumova EN, Gorski J. The polyclonal CD8 T cell response to influenza M158-66 generates a fully connected network of cross-reactive clonotypes to structurally related peptides: a paradigm for memory repertoire coverage of novel epitopes or escape mutants. J Immunol. 2011 Jun 1;186(11):6390-7. PMID: 21518969.
GPR17 agonist, NMDA and fructose 1,6-bisphospha...
FLT3, c-Kit, PDGFR inhibitor.
Antacid; pepsin inhibitor. Assay (Polysaccharid...
Bactericidal
AMPK activator.
Furanolactone found in Citrus.
Synthetic non-digestible disaccharide.
Histamine H1 antagonist, FIASMA.
Alkaloid found in Corydalis and Stephania; D1/2...
mTOR activator.
Calcium channel blocker.
RyR agonist, SIRT, telomerase, P2Y, GPCR inhibi...
Diterpene found in tobacco plants and cigarette...
Galactose-derived hexosamine sugar, component o...
Peptide, vSrc-induced cytokine.
SK K+ channel blocker, EGFR inhibitor.
Antibacterial (Antimyobacterial) agent.
Ansamycin; bacterial DNA-dependent RNA polymera...
Oxazolidone derivative; Factor Xa inhibitor.
PKC and PKD activator, carcinogen.